Flu@home: the Comparative Accuracy of an At-Home Influenza Rapid Diagnostic Test Using a Prepositioned Test Kit, Mobile App, Mail-in Reference Sample, and Symptom-Based Testing Trigger-Reference-Cited by-同舟云学术

Flu@home: the Comparative Accuracy of an At-Home Influenza Rapid Diagnostic Test Using a Prepositioned Test Kit, Mobile App, Mail-in Reference Sample, and Symptom-Based Testing Trigger

Published:2022-03-16 Issue:3 Volume:60 Page:
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Kotnik Jack Henry¹²,Cooper Shawna³,Smedinghoff Sam³,Gade Piyusha⁴,Scherer Kelly⁴,Maier Mitchell⁴,Juusola Jessie⁴,Ramirez Ernesto⁴,Naraghi-Arani Pejman⁵,Lyon Victoria²,Lutz Barry¹,Thompson Matthew²

Affiliation:

1. Department of Bioengineering, University of Washington, Seattle, Washington, USA

2. Department of Family Medicine, University of Washington, Seattle, Washington, USA

3. Audere, Seattle, Washington, USA

4. Evidation Health, Inc., San Mateo, California, USA

5. Tunnell Government Services, Inc., Bethesda, Maryland, USA

Abstract

At-home testing with rapid diagnostic tests (RDTs) for respiratory viruses could facilitate early diagnosis, guide patient care, and prevent transmission. Such RDTs are best used near the onset of illness when viral load is highest and clinical action will be most impactful, which may be achieved by at-home testing.

Funder

HHS | Biomedical Advanced Research and Development Authority

Bill and Melinda Gates Foundation

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/jcm.02070-21

Reference68 articles.

1. The Global Burden of Respiratory Disease

2. Economic burden of seasonal influenza in the United States